Overall Survival in Advanced Stage Mantle Cell Lymphoma after Early Autologous Stem Cell Transplantation with Cisplatin, Etoposide ,Cytarabine and Melphalan (PEAM) As a Conditioning Regimen

被引：0
|
作者：
Franco, Daniel [1 ]
Tellez, Fernando [1 ]
Solis-Armenta, Ruben [1 ]
Leal Alanis, Araceli [1 ]
Cruz Castillo, Carlos [2 ]
Valero Saldana, Luis Manuel [1 ]
Acosta Maldonado, Brenda Lizeth [2 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
[2] Inst Natl Cancerol, Dept Hematol, Mexico City, DF, Mexico
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-191183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Overall survival in advanced stage mantle cell lymphoma after early autologous stem cell transplantation with cisplatin, etoposide, cytarabine and melphalan (peam) as a conditioning regimen
    Franco-Saenz, D.
    Acosta-Maldonado, B. L.
    Tellez-Manriquez, J. F.
    Valero-Saldana, L. M.
    Gutierrez-Gutierrez, B.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 171 - 171
  • [2] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [3] TEAM (thiotepa, etoposide, cytarabine, melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M.
    Merla, E.
    Dell'Olio, M.
    Scalzulli, P.
    Capalbo, S.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S214 - S214
  • [4] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M. M.
    Merla, E.
    Dell'Olio, M.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Musto, P.
    Rana, A.
    Guarini, A.
    Di Tonno, P.
    Pastore, D.
    D'Elia, M.
    Specchia, G.
    Capalbo, S.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S248 - S248
  • [5] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Ferrara, F.
    Greco, M.
    Dell'Olio, M.
    Scalzulli, P.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Capalbo, S.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 66 - 66
  • [6] Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
    Zhang, Lihong
    Yang, Haifei
    Qian, Chongsheng
    Zhou, Jihao
    Zhu, Qian
    Jiang, Yibin
    Liu, Shuo
    Chen, Xiaochen
    Xu, Ting
    Qu, Changju
    Li, Caixia
    Jin, Zhengming
    Chu, Jianhong
    Zhang, Xinyou
    Wu, Depei
    Huang, Haiwen
    HEMATOLOGY, 2022, 27 (01) : 404 - 411
  • [7] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [8] Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
    Lin, Meng
    Wu, Xiaolong
    Zhang, Lei
    Li, Ling
    Wang, Xinhua
    Fu, Xiaorui
    Sun, Zhenchang
    Zhang, Xudong
    Zhu, Linan
    Yu, Hui
    Chang, Yu
    Nan, Feifei
    Yan, Jiaqin
    Zhou, Zhiyuan
    Shi, Cunzhen
    Zhang, Mingzhi
    Li, Xin
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 605 - 612
  • [9] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [10] Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Won-Sik
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Choi, Yun Suk
    Bae, Seong Hwa
    BONE MARROW TRANSPLANTATION, 2019, 54 : 209 - 210
12345